Trilogy Capital’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.93M Sell
41,699
-6
-0% -$572 0.15% 111
2026
Q2
$3.53M Buy
41,705
+2,148
+5% +$173K 0.14% 126
2026
Q1
$2.8M Buy
39,557
+1,123
+3% +$84.1K 0.12% 131
2025
Q4
$3.03M Buy
+38,434
New +$3.04M 0.14% 127
2018
Q4
– Sell
-31
Closed -$1K – 397
2018
Q3
$1K Hold
31
– – ﹤0.01% 570
2018
Q2
$1K Sell
31
-3
-9% -$140 ﹤0.01% 529
2018
Q1
$2K Buy
+34
New +$1.65K ﹤0.01% 393

Other funds holding MET

Trilogy Capital's MET Position: Q3 2026 in Review

Trilogy Capital reduced its MetLife (MET) stake by 0.01% in Q3 2026, selling an estimated $572 and leaving 41,699 shares worth $3.93M. The position accounts for 0.15% of the portfolio, ranked #111.

Trilogy Capital first reported a position in MET in Q1 2018 and has held it in 7 quarters since. 382 funds tracked by Wall St. Rank hold MET as of Q3 2026.

  • Trilogy Capital held 41,699 shares of MetLife worth $3.93M as of Q3 2026.
  • Trilogy Capital sold 6 MetLife shares in Q3 2026, an estimated $572.
  • MetLife made up 0.15% of Trilogy Capital's portfolio in Q3 2026, its #111 holding.
  • Trilogy Capital first reported a position in MetLife in Q1 2018 and has held it in 7 quarters since.
  • 382 funds tracked by Wall St. Rank held MetLife as of Q3 2026.

Based on Trilogy Capital's 13F filing for Q3 2026, filed 20 Oct 2026.